<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778657</url>
  </required_header>
  <id_info>
    <org_study_id>APHP210274</org_study_id>
    <nct_id>NCT04778657</nct_id>
  </id_info>
  <brief_title>National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell</brief_title>
  <acronym>COHSTO</acronym>
  <official_title>National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hereditary stomatocytosis is a heterogeneous group of rare constitutional diseases of&#xD;
      dominant transmission in the vast majority of cases. The data concerning their clinical and&#xD;
      biological presentation, and their evolution are few, and come from about thirty clinical&#xD;
      cases. The constitution of an exhaustive French cohort of hereditary stomatocytosis will&#xD;
      improve the establishment of the diagnosis and the management of patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patient is prospectively included. The referring hematologist will inform the patient&#xD;
      about participation in the cohort, give him the information note and obtain his non-objection&#xD;
      agreement to the use of his data for research purposes.&#xD;
&#xD;
      The data will be collected from the medical file of each patient as part of his usual annual&#xD;
      follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2041</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2041</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>15 Years</target_duration>
  <primary_outcome>
    <measure>Obtain a description of the clinical and laboratory data of patients at the time of diagnosis of stomatocytosis</measure>
    <time_frame>Baseline</time_frame>
    <description>Descriptive analysis of clinical and biological data for the diagnosis of stomatocytosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the proportion of recurrent genetic mutations and private mutations within our cohort</measure>
    <time_frame>Baseline</time_frame>
    <description>Number of recurrent genetic mutations and private mutations within our cohort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Establish phenotypes-genotypes relationships</measure>
    <time_frame>through study completion, an average of 15years</time_frame>
    <description>Specify the phenotypic presentation of each mutation and isolate any correlations genotype-phenotype</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the appearance of complications</measure>
    <time_frame>through study completion, an average of 15years</time_frame>
    <description>Rate of occurrence of complications over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe possible new phenotypic presentations of hereditary stomatocytosis</measure>
    <time_frame>through study completion, an average of 15years</time_frame>
    <description>Description of the phenotypic presentations of hereditary stomatocytosis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stomatocytosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        all patients for whom the diagnosis of hereditary stomatocytosis has been made or confirmed&#xD;
        by ektacytometry&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any patient with a diagnosis of stomatocytosis without age limit&#xD;
&#xD;
          -  Patient affiliated or beneficiary of french Social Security&#xD;
&#xD;
          -  No objection from the patient or legal representative&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of stomatocytosis excluded by ektacytometry and / or genetics&#xD;
&#xD;
          -  Patient under guardianship, with curators or legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corinne GUITTON</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Corinne GUITTON, MD,PhD</last_name>
    <phone>01 45 21 32 47</phone>
    <email>corinne.guitton@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-HP, Bicêtre Hospital, Pediatrics - Hematology - Reference center for Sickle cell anemia, Thalassemia and other constitutional diseases of the red blood cell</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne GUITTON, MD</last_name>
      <phone>+33 (0) 1 45 21 32 47</phone>
      <email>corinne.guitton@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rare genetic disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Hemolytic, Congenital</mesh_term>
    <mesh_term>Channelopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

